Lack of LDL Receptor Enhances Amyloid Deposition and Decreases Glial Response in an Alzheimer's Disease Mouse Model

Jul 15, 2011PloS one

Missing LDL receptor increases amyloid buildup and lowers immune cell activity in an Alzheimer's mouse model

AI simplified

Abstract

4-month-old 5XFAD transgenic mice lacking low-density lipoprotein receptors () show increased amyloid plaque deposition.

  • LDLR deficiency is associated with reduced astrocytosis and microgliosis in 5XFAD transgenic mice.
  • deletion decreases amyloid plaque formation but does not affect glial responses in 5XFAD mice.
  • 5XFAD mice lacking both ApoE and LDLR exhibit increased amyloid deposition along with decreased inflammatory responses.
  • Findings suggest that LDLR influences glial cell activity and amyloid plaque accumulation independently of ApoE.

AI simplified

Key numbers

5 of 7
Increase in Amyloid Plaque Deposition
5XFAD/-/- mice showed increased Thioflavine-S positive amyloid deposits compared to 5XFAD mice.
5 of 7
Decrease in Glial Response
5XFAD/-/- mice displayed reduced astrocytic and microglial response compared to control.

Full Text

What this is

  • The study investigates the role of the () in Alzheimer's disease (AD) using a mouse model.
  • deficiency is shown to increase amyloid plaque deposition while decreasing astrocytic and microglial responses.
  • The findings suggest that regulates glial responses independently of (), a key factor in AD pathology.

Essence

  • deficiency increases amyloid plaque deposition in an AD mouse model while reducing the glial response, independent of levels.

Key takeaways

  • deficiency leads to increased amyloid plaque deposition in 5XFAD mice. This effect occurs regardless of presence, indicating 's role in amyloid pathology.
  • The absence of correlates with a significant decrease in astrocytic and microglial responses, suggesting that may modulate neuroinflammation in AD.

Caveats

  • The study focuses on a specific mouse model, which may limit the generalizability of the findings to human AD pathology.
  • Results are based on comparisons among genetically modified mice, which may introduce variability related to genetic background.

Definitions

  • Apolipoprotein E (ApoE): A cholesterol carrier protein that plays a significant role in lipid metabolism and is a major genetic risk factor for Alzheimer's disease.
  • Low-density lipoprotein receptor (LDLR): A receptor that regulates cholesterol levels in the body and is implicated in the pathology of Alzheimer's disease.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free